Work

Fulminant Mixed Cardiac Allograft Rejection with Atypical Biopsy Findings and Negative MMDx Treated with VA-ECMO, Bortezomib, Eculizumab, and Daratumumab

FWCI:
Cites:
Cited by:
Related to: 10